Company intelligence / Profile preview

Bimeda

Dublin, Leinster, Irelandbimedaus.com ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Bimeda develops and markets a wide range of commercialized veterinary pharmaceuticals and vaccines used worldwide to optimize animal health. The company continues to expand its product lines through R&D investment and strategic acquisitions. Recent launches include new antiparasitic injectables such as MoxiSolv Injection.

Therapeutic areas: DermatologyEndocrinologyInfectious Diseases
Modalities: Small molecule (veterinary pharmaceuticals)Vaccine (biologicals for livestock and swine)Protein (e.g., hormone/reproduction products)Nutritional supplement
Industry: Veterinary

Drug pipeline

3 assets

MoxiSolv

Commercial

Indications: Animal parasitic infections

2 more assets in the full pipeline.

Request access →

Partnerships

Member of Generic Animal Drug AllianceCollaborations with academic institutions such as UCD Foundation/UCD Lyons Farm AgTech Innovation Centre

Beyond the preview

Go deeper on Bimeda.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bimeda.

Explore the full profile